PTC Therapeutics PTCT Investment Proceeds
Investment Proceeds at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt.
The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's investment proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is PTC Therapeutics's investment proceeds?
- PTC Therapeutics (PTCT) reported investment proceeds of $376.36M in Q1 2026.
- How has PTC Therapeutics's investment proceeds changed year-over-year?
- PTC Therapeutics's investment proceeds increased by 175.2% year-over-year, from $136.75M to $376.36M.
- What is the long-term trend for PTC Therapeutics's investment proceeds?
- Over 3 years (2021 to 2025), PTC Therapeutics's investment proceeds has grown at a -2.4% compound annual growth rate (CAGR), from $843.5M to $783.9M.
- What does investment proceeds mean?
- Cash received from sales, maturities, and redemptions of investment securities across all categories.